Literature DB >> 15545861

Coronaviruses: from common colds to severe acute respiratory syndrome.

Susan C Baker1.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15545861     DOI: 10.1097/01.inf.0000145815.70485.f7

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  8 in total

1.  Systematic assembly of a full-length infectious clone of human coronavirus NL63.

Authors:  Eric F Donaldson; Boyd Yount; Amy C Sims; Susan Burkett; Raymond J Pickles; Ralph S Baric
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

2.  Analysis of murine hepatitis virus strain A59 temperature-sensitive mutant TS-LA6 suggests that nsp10 plays a critical role in polyprotein processing.

Authors:  Eric F Donaldson; Rachel L Graham; Amy C Sims; Mark R Denison; Ralph S Baric
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

3.  Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor.

Authors:  John S Mills
Journal:  Biochim Biophys Acta       Date:  2006-06-06

Review 4.  Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.

Authors:  Jiang Du; Han Li; Jie Lian; Xinxing Zhu; Liang Qiao; Juntang Lin
Journal:  Stem Cell Res Ther       Date:  2020-05-24       Impact factor: 6.832

5.  Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse.

Authors:  Melissa Coughlin; Gin Lou; Osvaldo Martinez; Stephanie K Masterman; Ole A Olsen; Angelica A Moksa; Michael Farzan; John S Babcook; Bellur S Prabhakar
Journal:  Virology       Date:  2006-12-11       Impact factor: 3.616

6.  Impact of human coronavirus infections in otherwise healthy children who attended an emergency department.

Authors:  Susanna Esposito; Samantha Bosis; Hubert G M Niesters; Elena Tremolati; Enrica Begliatti; Alessandro Rognoni; Claudia Tagliabue; Nicola Principi; Albert D M E Osterhaus
Journal:  J Med Virol       Date:  2006-12       Impact factor: 2.327

Review 7.  Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?

Authors:  Sudha Warrier; S Mohana Sundaram; Lavanya Varier; Ananthakrishnan Balasubramanian
Journal:  Placenta       Date:  2021-12-06       Impact factor: 3.481

8.  Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms.

Authors:  Melissa M Coughlin; John Babcook; Bellur S Prabhakar
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.